---

---

sector : Health technology    entities : Sanofi   

save search

---

Sobi Q1 2024 report: Strong sales reflecting the strength of the portfolio
Published: 2024-04-25 (Crawled : 08:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| Email alert Add to watchlist
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| Email alert Add to watchlist
sales

---

Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance
Published: 2024-04-25 (Crawled : 06:00) - globenewswire.com
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| Email alert Add to watchlist
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| Email alert Add to watchlist
sales sanofi growth

---

Dassault Systèmes Reports Solid First Quarter Results And Reaffirms Full-Year Objectives
Published: 2024-04-25 (Crawled : 05:00) - globenewswire.com
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| Email alert Add to watchlist
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| Email alert Add to watchlist
first results

---

Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
Published: 2024-04-25 (Crawled : 02:00) - prnewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| Email alert Add to watchlist
asco meeting

---

First Approval for Rare Pediatric Cancer; New OTC Opioid Overdose Option
Published: 2024-04-24 (Crawled : 16:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -0.27% | O: 0.8% H: 0.0% C: -1.05%
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| 2.43% | O: -0.03% H: 2.66% C: 2.46%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -1.02% | O: -1.02% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -0.65% | O: -0.82% H: 0.37% C: 0.17%
XOMA | $25.11 -3.76% -3.9% 8.2K |

Health Technology

| -1.72% | O: 0.19% H: 0.0% C: -1.91%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 0.82% | O: 0.82% H: 0.0% C: 0.0%
rare first opioid approval for

---

CureVac Appoints Thaminda Ramanayake as New Chief Business Officer
Published: 2024-04-24 (Crawled : 15:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -0.27% | O: 0.8% H: 0.0% C: -1.05%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -1.02% | O: -1.02% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 0.82% | O: 0.82% H: 0.0% C: 0.0%
CVAC | $2.51 -3.46% -3.59% 1.1M |

Health Technology

| -3.46% | O: -4.62% H: 4.44% C: 1.21%
business

---

Lantern Pharma Launches “Webinar Wednesdays” Featuring World-Class Physician Scientists & Key Opinion Leaders Discussing Critical Areas of Oncology Drug Development
Published: 2024-04-24 (Crawled : 14:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -0.27% | O: 0.8% H: 0.0% C: -1.05%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 0.82% | O: 0.82% H: 0.0% C: 0.0%
LTRN | News | $5.44 -5.72% -6.07% 96K |

Health Technology

| -6.76% | O: 1.21% H: 2.91% C: -7.88%
pharma drug key leaders development

---

Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
Published: 2024-04-24 (Crawled : 14:00) - globenewswire.com
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -0.27% | O: 0.8% H: 0.0% C: -1.05%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 0.82% | O: 0.82% H: 0.0% C: 0.0%
REGN | News | $906.55 -0.09% -0.08% 370K |

Health Technology

| -0.09% | O: -0.05% H: 0.97% C: -0.04%
asco tumors treatment blood for

---

Sanofi Layoffs, CAR-T Warnings and a New GLP-1 Player
Published: 2024-04-24 (Crawled : 13:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -0.27% | O: 0.8% H: 0.0% C: -1.05%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 0.82% | O: 0.82% H: 0.0% C: 0.0%
car-t sanofi

---

CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
Published: 2024-04-24 (Crawled : 13:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -0.27% | O: 0.8% H: 0.0% C: -1.05%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 0.82% | O: 0.82% H: 0.0% C: 0.0%
CVAC | $2.51 -3.46% -3.59% 1.1M |

Health Technology

| -3.46% | O: -4.62% H: 4.44% C: 1.21%
BNTX | News | $88.18 -0.35% -0.35% 280K |

Health Technology

| -0.45% | O: 0.11% H: 0.97% C: -0.56%
business update for financial results

---

Biopharma Layoff Tracker 2024: Tessera, BMS, Pfizer and More Cut Staff
Published: 2024-04-24 (Crawled : 12:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -0.27% | O: 0.8% H: 0.0% C: -1.05%
RLYB | News | $1.59 -8.62% -9.43% 280K |

| -12.47% | O: -3.05% H: 0.0% C: -9.71%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -1.02% | O: -1.02% H: 0.0% C: 0.0%
VXRT | News | $0.7051 -5.41% -5.72% 1.5M |

Health Technology

| -8.39% | O: -1.94% H: 0.0% C: -6.58%
TXMD | News | $1.88 -0.27% 15K |

Health Technology

| 2.13% | O: 0.53% H: 2.12% C: 1.59%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 0.82% | O: 0.82% H: 0.0% C: 0.0%
PTCT | News S | $25.19 -0.87% -0.87% 560K |

Health Technology

| -2.95% | O: -0.71% H: 0.81% C: -2.25%
NKTR | News | $1.39 -2.11% -2.16% 960K |

Health Technology

| -0.36% | O: -1.08% H: 3.65% C: 0.73%
MOR | News | $18.07 0.17% 0.17% 130K |

Health Technology

| 0.06% | O: 0.0% H: 0.28% C: 0.06%
GLPG | News | $28.78 -2.28% -2.33% 140K |

Health Technology

| -1.41% | O: 0.48% H: 0.17% C: -1.88%
AMRN | News | $0.8844 0.13% 0.12% 660K |

Health Technology

| 0.57% | O: 0.57% H: 1.14% C: 0.0%
GOOGL | News 4 | $159.18 0.58% 0.58% 22M |

Technology Services

| 1.34% | O: 0.29% H: 1.31% C: 1.04%
GOOG | News 4 | $161.05 0.71% 0.7% 19M |

Technology Services

| 1.58% | O: 0.32% H: 1.45% C: 1.26%
OCX | News | $2.3 -6.31% -6.74% 41K |

Health Technology

| 0.0% | O: 2.03% H: 0.0% C: -1.99%
biopharma

---

Biopharma Layoff Tracker 2024: Tessera, BenevolentAI, Pfizer and More Cut Staff
Published: 2024-04-24 (Crawled : 05:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -0.27% | O: 0.8% H: 0.0% C: -1.05%
RLYB | News | $1.59 -8.62% -9.43% 280K |

| -12.47% | O: -3.05% H: 0.0% C: -9.71%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -1.02% | O: -1.02% H: 0.0% C: 0.0%
VXRT | News | $0.7051 -5.41% -5.72% 1.5M |

Health Technology

| -8.39% | O: -1.94% H: 0.0% C: -6.58%
TXMD | News | $1.88 -0.27% 15K |

Health Technology

| 2.13% | O: 0.53% H: 2.12% C: 1.59%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 0.82% | O: 0.82% H: 0.0% C: 0.0%
PTCT | News S | $25.19 -0.87% -0.87% 560K |

Health Technology

| -2.95% | O: -0.71% H: 0.81% C: -2.25%
NKTR | News | $1.39 -2.11% -2.16% 960K |

Health Technology

| -0.36% | O: -1.08% H: 3.65% C: 0.73%
MOR | News | $18.07 0.17% 0.17% 130K |

Health Technology

| 0.06% | O: 0.0% H: 0.28% C: 0.06%
GLPG | News | $28.78 -2.28% -2.33% 140K |

Health Technology

| -1.41% | O: 0.48% H: 0.17% C: -1.88%
AMRN | News | $0.8844 0.13% 0.12% 660K |

Health Technology

| 0.57% | O: 0.57% H: 1.14% C: 0.0%
GOOGL | News 4 | $159.18 0.58% 0.58% 22M |

Technology Services

| 1.34% | O: 0.29% H: 1.31% C: 1.04%
GOOG | News 4 | $161.05 0.71% 0.7% 19M |

Technology Services

| 1.58% | O: 0.32% H: 1.45% C: 1.26%
OCX | News | $2.3 -6.31% -6.74% 41K |

Health Technology

| 0.0% | O: 2.03% H: 0.0% C: -1.99%
biopharma

---

Curio Digital Therapeutics Inc. Announces the U.S. Food and Drug Administration (FDA) Clearance of MamaLift Plus™, the First Prescription Digital Therapeutic Authorized for the Treatment of Postpartum Depression (PPD)
Published: 2024-04-23 (Crawled : 00:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 2.53% | O: 1.7% H: 0.0% C: 0.0%
first drug authorized food depression treatment clearance for therapeutics

---

Biopharma Layoff Tracker 2024: BenevolentAI, Pfizer, Sanofi and More Cut Staff
Published: 2024-04-23 (Crawled : 14:30) - biospace.com/
RLYB | News | $1.59 -8.62% -9.43% 280K |

| -10.73% | O: 1.98% H: 0.0% C: 0.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -0.13% | O: 0.89% H: 0.0% C: 0.0%
VXRT | News | $0.7051 -5.41% -5.72% 1.5M |

Health Technology

| -6.58% | O: 1.97% H: 0.0% C: 0.0%
TXMD | News | $1.88 -0.27% 15K |

Health Technology

| 2.13% | O: -0.53% H: 1.07% C: 0.53%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 2.53% | O: 1.7% H: 0.0% C: 0.0%
PTCT | News S | $25.19 -0.87% -0.87% 560K |

Health Technology

| -2.93% | O: 0.02% H: 0.0% C: 0.0%
NKTR | News | $1.39 -2.11% -2.16% 960K |

Health Technology

| 1.47% | O: 1.84% H: 0.0% C: 0.0%
MOR | News | $18.07 0.17% 0.17% 130K |

Health Technology

| 0.45% | O: 0.39% H: 0.0% C: 0.0%
GLPG | News | $28.78 -2.28% -2.33% 140K |

Health Technology

| -1.03% | O: 0.38% H: 0.0% C: 0.0%
AMRN | News | $0.8844 0.13% 0.12% 660K |

Health Technology

| 1.15% | O: 0.57% H: 0.0% C: 0.0%
GOOGL | News 4 | $159.18 0.58% 0.58% 22M |

Technology Services

| 1.82% | O: 0.48% H: 0.0% C: 0.0%
GOOG | News 4 | $161.05 0.71% 0.7% 19M |

Technology Services

| 1.99% | O: 0.41% H: 0.0% C: 0.0%
OCX | News | $2.3 -6.31% -6.74% 41K |

Health Technology

| -1.99% | O: -1.99% H: 0.0% C: 0.0%
biopharma sanofi

---

Response Pharmaceuticals’ Drug Candidate for the Treatment of Antipsychotic-Induced Weight Gain (AIWG) Achieves Primary Endpoint in Phase 1b Clinical Trial
Published: 2024-04-23 (Crawled : 14:30) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 2.53% | O: 1.7% H: 0.0% C: 0.0%
drug candidate treatment for trial response

---

FDA Rejects Abeona’s Gene Therapy, Approves ImmunityBio’s Bladder Cancer Treatment
Published: 2024-04-23 (Crawled : 13:30) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| 3.89% | O: 0.13% H: 1.89% C: 1.3%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -0.13% | O: 0.89% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -0.17% | O: 0.56% H: 0.41% C: -0.07%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 2.53% | O: 1.7% H: 0.0% C: 0.0%
fda bladder cancer treatment

---

Sanofi’s $3.7B Principia Buy Starts to Pay Off with Phase III Rilzabrutinib Win
Published: 2024-04-23 (Crawled : 13:30) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 2.53% | O: 1.7% H: 0.0% C: 0.0%

---

Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
Published: 2024-04-23 (Crawled : 05:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 2.53% | O: 1.7% H: 0.0% C: 0.0%
study

---

Over-The-Counter Drug Market size is set to grow by USD 58.54 billion from 2023-2027, Abbott Laboratories, Achelios Therapeutics Inc. and AstraZeneca Plc, and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-04-22 (Crawled : 22:00) - prnewswire.com
RBGPF | News | $52.06 6.46% 4.8K |

Consumer Non-Durables

| 3.61% | O: 0.98% H: 5.46% C: -0.89%
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| -2.22% | O: -3.15% H: 0.0% C: -0.61%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| -2.44% | O: 0.96% H: 2.38% C: 0.17%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| 0.94% | O: 1.69% H: 0.02% C: -0.74%
RBGLY | News | $10.59 -2.05% 850K |

Manufacturing

| 3.68% | O: -0.28% H: 2.18% C: 1.99%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 3.78% | O: 4.32% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 0.67% | O: 0.17% H: 1.48% C: 1.43%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -0.17% | O: 0.56% H: 0.41% C: -0.07%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 2.53% | O: 1.7% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 1.53% | O: 0.4% H: 0.0% C: 0.0%
drug astrazeneca set key therapeutics market

---

Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)
Published: 2024-04-22 (Crawled : 22:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| 2.53% | O: 1.7% H: 0.0% C: 0.0%
REGN | News | $906.55 -0.09% -0.08% 370K |

Health Technology

| 0.61% | O: 0.51% H: 0.78% C: 0.18%
genetic cell research therapy

---

Gainers vs Losers

62%

38%

Top 10 Gainers

CSSE 4 | $0.4323 183.85% 64.77% 220M |

Consumer Services

BOF | $1.99 70.09% 41.21% 110M |

ILAG | $0.51 6.03% 40.62% 1.7M |

LICN | $0.941 68.04% 40.49% 15M |

AMST | $3.31 65.5% 39.58% 70M |

Technology Services

MTC | $3.615 61.38% 38.04% 9.3M |

Technology Services

WIMI | $1.15 58.53% 36.92% 19M |

Technology Services

AIH | $0.45 12.5% 30.92% 320K |

Health Services

MULN | News | $3.78 38.46% 27.78% 13M |

Information

RILY | $29.86 37.48% 27.26% 12M |

Finance

---

Your saved searches

---